Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain

References

• Casellini CM, Vinik AI. Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract 2007;13:550-66
   PubMedGoogle Scholar
• Cole BE. Diabetic peripheral neuropathic pain: recognition and management. Pain Med 2007;8:S27-32
   PubMed Web of Science ®Google Scholar
• Boulton AJ. Management of diabetic peripheral neuropathy. Clin Diabetes. 2005;23:9-15
   Google Scholar
• Boulton AJ, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86
   PubMed Web of Science ®Google Scholar
• Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-82
   PubMed Web of Science ®Google Scholar
• Argoff CE, Cole BE, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality of life issues. Mayo Clin Proc 2006;81(4 Suppl):S3-11
   Google Scholar
• Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008;22:417-42
   PubMed Web of Science ®Google Scholar
• Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabet Res Clini Pract 2000;47:123-8
   PubMed Web of Science ®Google Scholar
• Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007;68:1178-82
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-85
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients’ perspectives. J Pain 2006;7:892-900
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathic Study. Neurology 1993;43:817-24
   PubMed Web of Science ®Google Scholar
• Hamalainen H, Ronnemaa T, Halonen JP, et al. Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: a population-based 7-year follow-up study. J Intern Med 1999;246:97-103
   PubMed Web of Science ®Google Scholar
• Susztak K, Bottinger EP. Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol 2006;17:361-7
   PubMed Web of Science ®Google Scholar
• Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc 2006;4:18
   PubMedGoogle Scholar
• Able SL, Robinson RL, Sterling K, et al Utilization and costs of pain medications by patients with diabetic neuropathy. Presented at: Annual Meeting of the Academy of Managed Care Pharmacy, Denver, CO, April 20-25, 2005
   Google Scholar
• Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc 2006;81(4 Suppl):S12-25
   Google Scholar
• Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev 1987;77:251-77
   PubMed Web of Science ®Google Scholar
• Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998;7:283-95
   Google Scholar
• Lipscomb J, Ancukiewicz M, Parmigiani G, et al. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998;18(2 Suppl):S39-56
   PubMedGoogle Scholar
• Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983;78:605-10
   Web of Science ®Google Scholar
• Boulanger L, Zhao Y, Bao Y, et al. A retrospective study of factors associated with healthcare resource use and costs among patients with diabetic neuropathy. Working paper, 2008
   Google Scholar
• Hall GC, Carroll D, Parry D, et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122:156-62
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Woehl A, et al. The financial costs of healthcare treatment for people with type 1 or type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007;24:187-94
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Woehl A, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006;49:2272-80
   PubMed Web of Science ®Google Scholar